InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PEB | Ann: Change in substantial holding | 19/09/24 | 0 | 1 | |||
|
|||||||
PEB | Ann: Cxbladder Adoption Roll-Out Advances in New Zealand | 27/03/19 | 2 | 643 | |||
|
|||||||
PEB | Ann: PACIFIC EDGE SUCCESSFULLY COMPLETES CAPITAL RAISING | 26/02/19 | 2 | 319 | |||
|
|||||||
PEB | Ann: NZXR Share Price Enquiry into Pacific Edge Limited | 14/02/19 | 0 | 175 | |||
|
|||||||
PEB | Ann: SPH Notice - First NZ Capital Group Limited | 04/02/19 | 0 | 143 | |||
|
|||||||
PEB | Ann: D&O Ongoing Disclosures - Multiple | 04/02/19 | 0 | 132 | |||
|
|||||||
PEB | Ann: Notification of Allotment of Securities | 31/01/19 | 0 | 121 | |||
|
|||||||
PEB | Ann: Interim Report 2018 | 19/12/18 | 0 | 233 | |||
|
See All Discussions